A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib and Bendamustine to Treat Relapsed/Refractory Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
UARK 2010-35, A Study of Expanded Natural Killer Cell Therapy for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
- Status
- TERMINATED
- Phase
- PHASE2
Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Velcade Consolidation Bone Study
- Status
- COMPLETED
- Phase
- PHASE2
Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)
- Status
- COMPLETED
- Phase
- NA
Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating the Efficacy and Safety of the Lower Dose of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation- KMM103 Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Combination of Midostaurin, Bortezomib, and Chemo in Relapsed/Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1